… Based on the available data, the cost-effectiveness of molecular markers in low-risk thyroid
tumors remains a subject of controversy, likely to be an intriguing topic for future research. …

… This study suggests that older age may be associated with a reduced risk of primary papillary
thyroid carcinoma tumor growth under active surveillance. Incident metastatic disease is …

… The approach to surgical management of such low-risk patients within our … controversy
about the most appropriate surgical treatment for low-/intermediate-risk T1T2N0/Nx thyroid cancer …

… However, some investigators have suggested that for papillary thyroid carcinoma (PTC),
there is an … as an alternative to immediate surgery, which has been controversial 10 . Chinese …

… However, this issue will remain controversial. Our cases were asymptomatic and the
metastatic lymph node was found incidentally in the third case. The patients may continue to live …

… in low-risk and very low-risk papillary thyroid cancer patients (ie, … very low-risk papillary
thyroid cancer (OR = 2.34 [CI 1.91–4.59]). … with low-risk thyroid cancer continue to be treated with …

… , very low-risk and low-risk papillary thyroid cancers can be managed with either thyroid …
surgery or active surveillance continues to be controversial among experts. Recently, the …

… The aim is to avoid subjecting low-risk patients to unnecessary diagnostic procedures and
… thyroid cancer. Cases are inputted in the database at the time of the initial treatment in the …

… None of the patients in this study died of thyroid carcinoma. … initial management option for
patients with low-risk PTMC. … such as cancer anxiety, the results have been controversial. Many …

… Association guidelines committee issued recommendations against RAI therapy for low-risk …
discouragement of RAI treatment for low-risk DTCs, and the subject remains controversial. …